Stay updated with breaking news from Ruth gimeno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The popularity of a new generation of weight-loss medicines is inspiring a growing number of drugmakers to pursue paths emulating Eli Lilly's highly-effective Zepbound, but Amgen is taking a unique approach. Zepbound, which promotes the most weight loss among treatment options currently on the market, stimulates two different gut hormones to fight obesity, GLP-1 and GIP. Amgen's most advanced experimental candidate activates GLP-1 while blocking GIP. ....
Lilly signs another AI deal, this one for obesity – Inside INdiana Business insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.
Fauna Bio, based in the San Francisco area, said Thursday it will give Lilly access to its AI platform, called Convergence, to support preclinical drug discovery efforts in obesity. ....
The $494 million deal gives Lilly access to Fauna’s Convergence AI platform, which analyzes data from hibernating animals to identify drug targets. ....
Fauna Bio Announces Strategic Collaboration with Lilly to Discover Novel Obesity Targets Using Convergencetm AI Platform lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.